Literature DB >> 17002978

RNase L: its biological roles and regulation.

Shu-Ling Liang1, David Quirk, Aimin Zhou.   

Abstract

2'-5'oligoadenylate-dependent ribonuclease L (RNase L) is one of the key enzymes involved in the function of interferons (IFNs), a family of cytokines participating in innate immunity against viruses and other microbial pathogens. Upon binding with its activator, 5'-phosphorylated, 2'-5' linked oligoadenylates (2-5A), RNase L degrades single-stranded viral and cellular RNAs and thus plays an important role in the antiviral and antiproliferative functions of IFNs. In recent years, evidence has revealed that RNase L displays a broad range of biological roles which are summarized in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002978     DOI: 10.1080/15216540600838232

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  40 in total

1.  Structural architecture of an RNA that competitively inhibits RNase L.

Authors:  Amanda Y Keel; Babal Kant Jha; Jeffrey S Kieft
Journal:  RNA       Date:  2011-11-23       Impact factor: 4.942

Review 2.  All things must pass: contrasts and commonalities in eukaryotic and bacterial mRNA decay.

Authors:  Joel G Belasco
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-03       Impact factor: 94.444

Review 3.  Killing of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor.

Authors:  Elena M Glinka
Journal:  Tumour Biol       Date:  2015-04-01

4.  Interferon-gamma-mediated inhibition of serum response factor-dependent smooth muscle-specific gene expression.

Authors:  Zengdun Shi; Don C Rockey
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

Review 5.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

6.  Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation.

Authors:  Daochuan Li; Qing Wang; Caixia Liu; Huawei Duan; Xiaowen Zeng; Bo Zhang; Xiaodong Li; Jian Zhao; Shifu Tang; Zhifang Li; Xiumei Xing; Ping Yang; Liping Chen; Junling Zeng; Xiaonian Zhu; Shixin Zhang; Zhengbao Zhang; Lu Ma; Zhini He; Erman Wang; Yongmei Xiao; Yuxin Zheng; Wen Chen
Journal:  Toxicol Sci       Date:  2011-11-01       Impact factor: 4.849

7.  Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival.

Authors:  Athina Kladi-Skandali; Konstantinos Mavridis; Andreas Scorilas; Diamantis C Sideris
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-27       Impact factor: 4.553

Review 8.  Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies.

Authors:  Paulien Smits; Jan Smeitink; Lambert van den Heuvel
Journal:  J Biomed Biotechnol       Date:  2010-04-13

Review 9.  The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma.

Authors:  Yvonne Christley; Tim Duffy; Ian Paul Everall; Colin R Martin
Journal:  Curr Psychiatry Rep       Date:  2013-04       Impact factor: 5.285

10.  RNase L mediated protection from virus induced demyelination.

Authors:  Derek D C Ireland; Stephen A Stohlman; David R Hinton; Parul Kapil; Robert H Silverman; Roscoe A Atkinson; Cornelia C Bergmann
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.